Type 1 IFNs produced by irradiated tumour cells and tumour-infiltrating leukocytes can enhance dendritic cell cross-priming of CD8+ T-cells (cytolytic T cell) and concomitant T-cell mediated killing. The gene discussed is CD8A; the disease is neoplasm.